AI assistant
Sending…
Mersana Therapeutics, Inc. — Director's Dealing 2017
Sep 7, 2017
34702_dirs_2017-09-07_903575cd-00a8-4446-93cc-3454d4cf9241.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Mersana Therapeutics, Inc. (MRSN)
CIK: 0001442836
Period of Report: 2017-09-05
Reporting Person: Alleva Lawrence M (Director)
More from Mersana Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Jan 30
Major Shareholding Notification
2026
Jan 9
Major Shareholding Notification
2026
Jan 8
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6